Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
(OP:
LOBEF
)
0.0370
+0.0010 (+2.78%)
Streaming Delayed Price
Updated: 3:33 PM EDT, Oct 10, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
58,715
Open
0.0348
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0360
Today's Range
0.0316 - 0.0370
52wk Range
0.0082 - 0.0648
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Lobe Sciences Improves Balance Sheet
October 09, 2025
Via
ACCESS Newswire
Lobe Sciences Ltd. and Cynaptec Pharmaceuticals, Inc. to Present a New Therapeutic Approach for the Treatment of Chronic Cluster Headaches at Clusterbusters 2025
September 09, 2025
Via
ACCESS Newswire
Performance
YTD
+85.0%
+85.0%
1 Month
+6.9%
+6.9%
3 Month
+45.7%
+45.7%
6 Month
+32.1%
+32.1%
1 Year
+184.6%
+184.6%
More News
Read More
Lobe Sciences Announces the Appointment of Marco Mastrodonato to its Board of Directors
September 08, 2025
Via
ACCESS Newswire
Lobe Sciences Announces the Closing of the Previously Announced Private Placement
August 14, 2025
Via
ACCESS Newswire
Lobe Sciences Ltd. Engages ArcStone Securities for Strategic Capital Markets Advisory
July 29, 2025
Via
ACCESS Newswire
Lobe Sciences Ltd. Announces Debt Settlement
July 16, 2025
Via
ACCESS Newswire
Lobe Sciences Announces Validation of European Unitary Patent for DHA-Based Composition for Sickle Cell Disease
July 08, 2025
Via
ACCESS Newswire
Lobe Sciences Moves Forward with Development of Conjugated Psilocin(TM) Following April 14 Agreement to Spin Out Compound to Cynaptec Pharmaceuticals
June 17, 2025
Via
ACCESS Newswire
Lobe Sciences Appoints Mr. Yong Yao as Chief Financial Officer to Support Strategic Growth
June 03, 2025
Via
ACCESS Newswire
Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin(TM)
April 14, 2025
Via
ACCESS Newswire
Lobe Sciences Provides Corporate Update
April 04, 2025
Via
ACCESS Newswire
Lobe Sciences and Alera Pharma Announce Notice of Allowance for Second U.S. Patent for Conjugated Psilocin™
November 18, 2024
From
Lobe Sciences Ltd.
Via
Business Wire
Lobe Sciences, Ltd. Announces the Appointment of Enclave Capital and Peak Asset Management to Fund Clinical Trials of Conjugated Psilocin™
October 16, 2024
From
Lobe Sciences, Ltd.
Via
Business Wire
Lobe Sciences and Alera Pharma Announce Issuance of U.S. Patent for Conjugated Psilocin™
October 02, 2024
From
Lobe Sciences, Ltd.
Via
Business Wire
Lobe Sciences Announces Creation of Wholly Owned Subsidiary, Alera Pharma, Inc.
August 15, 2024
From
Lobe Sciences Ltd
Via
Business Wire
Lobe Sciences Announces Appointment of a New Board of Directors and Executive Management Team
August 12, 2024
From
Lobe Sciences Ltd
Via
Business Wire
Lobe Sciences Announces Update
June 04, 2024
From
Lobe Sciences Ltd.
Via
Business Wire
Wesley Ramjeet to Join Lobe Sciences’ Board of Directors, Bringing Decades of Strategic Financial Expertise
June 03, 2024
From
Lobe Sciences Ltd.
Via
Business Wire
Lobe Sciences Announces Frederick D. Sancilio Ph.D. to Join Board of Directors
May 31, 2024
From
Lobe Sciences Ltd.
Via
Business Wire
Former Merck Director and Vanderbilt Vice-Chancellor, Dr. Harry Jacobson, to Join Lobe Sciences Board of Directors
May 30, 2024
From
Lobe Sciences Ltd.
Via
Business Wire
Lobe Sciences Ltd. and Clearway Global Announce Change of Control and Focus on Creating Value for Shareholders
May 21, 2024
From
Lobe Sciences Ltd.
Via
Business Wire
Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
January 15, 2024
Via
Benzinga
Lobe Sciences Provides Company Review of 2023
January 08, 2024
From
Lobe Sciences Ltd.
Via
Business Wire
Lobe Sciences Provides Update on L-130 Clinical Program
December 07, 2023
From
Lobe Sciences Ltd.
Via
Business Wire
Lobe Sciences Provides Update on L-130 Oral Psilocin Compound
December 05, 2023
From
Lobe Sciences Ltd.
Via
Business Wire
Frequently Asked Questions
Is LOBEF publicly traded?
Yes, LOBEF is publicly traded.
What exchange does LOBEF trade on?
LOBEF trades on the OTC Traded
What is the ticker symbol for LOBEF?
The ticker symbol for LOBEF is LOBEF on the OTC Traded
What is the current price of LOBEF?
The current price of LOBEF is 0.0370
When was LOBEF last traded?
The last trade of LOBEF was at 10/10/25 03:33 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
Starting at $3.75
/
week.
Subscribe Today